FDA has approved safety labeling changes for fluorouracil injection products. This effort was a collaboration between FDA’s Office of Generic Drugs and the Oncology Center of Excellence.
Urologic oncologist Wayne Brisbane thought his patient might be a good candidate for focal therapy.
